Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
boston blog main
boston top stories
clinical trials
life sciences
national blog main
fda
ipo
tc
480 biomedical
ally bridge group
arsenal medical
big data analytics
biotech ipos
blackrock
bob langer
cannabis
casdin capital
chronic rhinosinusitis
covid-19
deals
diabetic nephropathy
drug delivery
dyne therapeutics
eventide asset management
focal segmental glomerulosclerosis
genzyme
george whitesides
goldfinch bio
inflammation
investing
irving investors
jay ghosh
keros therapeutics
lyra therapeutics
medical device
metacrine
mometasone furorate
myotonic dystrophy type 1
What
company
5
×
ipo
5
×
million
5
×
raised
developing
public
therapeutics
based
biotech
drug
genetic
medical
medicines
new
raises
shares
according
analysis
apiece
bio
bring
brings
british
cannabis
clinical
closing
columbia
deb
debut
debuted
develop
diseases
disorders
dyne
dyne’s
employing
estimated
filings
friday
fund
Language
unset
Current search:
ipo
×
million
×
company
×
@techcrunch.com
2 years ago
Rani Therapeutics’ $73M IPO will fund upcoming clinical trials
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@techcrunch.com
5 years ago
Public shareholders got high today on Tilray, the first marijuana company to IPO on Nasdaq